Beyond Meat (BYND) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Q4 2025 and full year marked by persistent weak demand in plant-based meat, leading to lower sales volumes, significant non-routine charges, and a 19.7% revenue decline in Q4 and 15.6% for the year.
Major transformation initiatives included retiring most 2027 convertible debt, raising $149 million in cash, and repositioning the brand to target adjacent categories, including the launch of Beyond Immerse beverage.
Significant SKU rationalization, asset write-downs, and exit from China operations impacted reported results.
Net income turned positive due to a $548.7 million non-cash gain on debt restructuring, despite significant operating losses.
Strategic repositioning to "Beyond The Plant Protein Company™" aims to stabilize top-line and expand margins.
Financial highlights
Q4 2025 net revenues: $61.6 million (down 19.7% YoY); full year: $275.5 million (down 15.6% YoY).
Gross margin dropped to 2.3% in Q4 and 2.8% for the year, impacted by non-cash charges and higher COGS.
Operating expenses surged to $134.2 million in Q4, mainly due to asset write-downs, litigation accrual, and stock compensation.
Q4 net income: $409.9 million (vs. $44.9 million loss prior year); full year net income: $219.9 million (vs. $160.3 million loss prior year), both driven by debt restructuring gain.
Adjusted EBITDA loss: $69.0 million in Q4 (vs. $26.0 million loss prior year); $178.4 million loss for the year (vs. $101.7 million loss prior year).
Outlook and guidance
Q1 2026 net revenues expected to be $57–$59 million, with continued uncertainty and low visibility in the core category.
No annual gross margin guidance provided due to volatility and soft volumes in plant-based meat.
Management highlights ongoing uncertainty in the operating environment and is limiting forward guidance.
Latest events from Beyond Meat
- Board proposes director elections, auditor ratification, and performance-based executive pay.BYND
Proxy filing10 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.BYND
Proxy filing10 Apr 2026 - Gross margin rose to 14.7% as net loss narrowed, despite an 8.8% revenue decline.BYND
Q2 20242 Feb 2026 - Q3 2024 net revenues rose 7.6% with margin gains and a narrowed net loss, but risks persist.BYND
Q3 202416 Jan 2026 - Registration enables resale of 9.56M shares from warrant exercise, raising up to $31.2M.BYND
Registration Filing16 Dec 2025 - Q4 2024 delivered revenue growth, margin gains, and restructuring to target future profitability.BYND
Q4 20242 Dec 2025 - Shareholders to vote on debt exchange, share increase, new equity plan, and reverse split.BYND
Proxy Filing1 Dec 2025 - 2024 saw revenue decline, cost cuts, and a shift to performance-based executive pay.BYND
Proxy Filing1 Dec 2025 - Shareholders to vote on recapitalization, major dilution, and governance overhaul proposals.BYND
Proxy Filing1 Dec 2025